Abstract
Both donor and recipient CYP3A5 gene polymorphisms represent as significant factors influencing Tacrolimus weight-dose adjusted concentration in the early phase after living donor liver transplantation
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have